Charleston, SC -- (SBWIRE) -- 01/21/2014 -- otcstockcenter.com, provide information specifically for trades in the micro-cap market. Micro caps are companies with a capitalization between $50 million and $300 million. We provide the information active traders need, when they need it. By combining our research capabilities with our instant alerts, subscribers are able to better determine trading strategies and execute those strategies faster. Let’s have a look on Few Hot Stocks: Cell Therapeutics Inc (NASDAQ:CTIC), Amarin Corporation plc (ADR) (NASDAQ:AMRN), Hemispherx BioPharma, Inc (NYSEMKT:HEB), NII Holdings Inc (NASDAQ:NIHD)
Cell Therapeutics Inc (NASDAQ:CTIC) was trading higher by 0.43 points or 11.81% to $4.07.So far, around 16.69 million shares have changed hands in this session. After opening at $4.01, the stock hit as high as $4.25. However, it traded between $0.97 and$4.25 over the last twelve months. Cell Therapeutics, Inc. (CTI) is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic ways to treats cancer. The Company is concentrating its efforts on treatments that target blood-related cancers where there is an unmet medical need.
For How Long CTIC will Fight for Profitability? Read This Trend Analysis report
Amarin Corporation plc (ADR) (NASDAQ:AMRN) was at $1.73, showing a -24.01% decrease. Around 14.24 million shares have been traded, versus an-average trading volume of 7.03M shares. The company is now valued at around $298.67 million. Amarin Corporation plc (Amarin) is a late-stage biopharmaceutical -company with expertise in lipid science focused on the treatment of cardiovascular disease. The Company’s product candidate is AMR101, an ultra-pure omega-3 fatty acid.
Has AMRN Found The Bottom And Ready To Gain Momentum? Find Out Here
Hemispherx BioPharma, Inc (NYSEMKT:HEB) moved 12.39 per cent higher at $0.464 and is trading between $0.44 and $0.51 after opening the day at $0.50. Its performance over the last five days remained 66.18%, which stands at 76.92% for a month. Going back further than one month, 1-year performance after recent close was 75.58%. Hemispherx Biopharma, Inc. (Hemispherx) is a specialty pharmaceutical company engaged in the clinical development of new drugs therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.
Will HEB Continue To Move Higher? Find Out Here
NII Holdings Inc (NASDAQ:NIHD) shares rose today, gaining per cent to $3.15. The stock is up around 14.18% in 2013 and -52.06% for the last 12 months. Around 14.70 million shares changed hands so far in this session compared to an-average trading volume of 7.10M shares. NII Holdings, Inc. (NII Holdings) is a holding company for the operations of Nextel Communications, Inc. in selected International markets. The Company provides wireless communication services under the Nextel brand.
Why Should Investors Buy NIHD After The Recent Gain? Just Go Here and Find Out
About OTC Stock Center
We provide the information active traders need, when they need it. By combining our research capabilities with our instant alerts, subscribers are able to better determine trading strategies and execute those strategies faster. More trades can mean more profits to those who can take advantage of the picks included with our service. We provide high quality picks in a timely fashion so that you are free to do what you do best, which is trade for profit. Alertness.
Markets move on information. Our subscribers get our picks fast and first by signing up for our email and text alerts. This information is exclusively for our readers, but once it’s out, the markets move and move fast. Getting the right information is always important, getting it first and in time to be able to build your trades is even more important. Don’t miss out on the chance to take your trading to the next level.
OTC Stock Center’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by OTC Stock Center or an offer or solicitation to buy or sell any security. Neither the owner of OTC Stock Center nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases.
Please read Our Full Disclaimer at: http://otcstockcenter.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)